Published : 23 Jun 2024
Aagami has received a new assignment as a result of one of the recently concluded BIO 2024 partnering event.
The assignment has come from a past client from Belgium. The client has an antibiotic-free selection technology in E. coli. The Selection Technology is based on Bacteriocin to Improve Microbial Fermentation
The main advantages of our selection technology for recombinant protein or plasmidic DNA are:
The assignment is to support the client in facilitating and closing licensing deals with few specific companies.
If you would like to know more about this partnering opportunity, please contact us.